- Home
- ONCY vs OPXS Comparison
ONCY vs OPXS Comparison
Compare ONCY & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- OPXS
- Stock Information
- Founded
- ONCY 1998
- OPXS 1987
- Country
- ONCY Canada
- OPXS United States
- Employees
- ONCY N/A
- OPXS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- OPXS Electronic Components
- Sector
- ONCY Health Care
- OPXS Technology
- Exchange
- ONCY Nasdaq
- OPXS Nasdaq
- Market Cap
- ONCY 49.2M
- OPXS 45.6M
- IPO Year
- ONCY 1999
- OPXS N/A
- Fundamental
- Price
- ONCY $0.56
- OPXS $5.71
- Analyst Decision
- ONCY Strong Buy
- OPXS
- Analyst Count
- ONCY 3
- OPXS 0
- Target Price
- ONCY $4.33
- OPXS N/A
- AVG Volume (30 Days)
- ONCY 330.3K
- OPXS 12.2K
- Earning Date
- ONCY 05-08-2025
- OPXS 05-13-2025
- Dividend Yield
- ONCY N/A
- OPXS N/A
- EPS Growth
- ONCY N/A
- OPXS 42.37
- EPS
- ONCY N/A
- OPXS 0.61
- Revenue
- ONCY N/A
- OPXS $35,225,000.00
- Revenue This Year
- ONCY N/A
- OPXS N/A
- Revenue Next Year
- ONCY N/A
- OPXS N/A
- P/E Ratio
- ONCY N/A
- OPXS $9.39
- Revenue Growth
- ONCY N/A
- OPXS 23.22
- 52 Week Low
- ONCY $0.47
- OPXS $5.36
- 52 Week High
- ONCY $1.53
- OPXS $10.30
- Technical
- Relative Strength Index (RSI)
- ONCY 45.75
- OPXS 50.50
- Support Level
- ONCY $0.47
- OPXS $5.50
- Resistance Level
- ONCY $0.65
- OPXS $5.75
- Average True Range (ATR)
- ONCY 0.05
- OPXS 0.27
- MACD
- ONCY 0.01
- OPXS 0.01
- Stochastic Oscillator
- ONCY 50.00
- OPXS 64.81
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.